In particular, miR-148b has been reported to be down-regulated in NSCLC and associated with poor survival [19] and it may function as a tumour suppressor in NSCLC by targeting carcinoembryonic antigen (CEA) [18]. Here, CEACAM5 is linked to non-small cell lung carcinoma.